EMEA-001136-PIP01-11-M01

Key facts

Invented name
Doptelet
Active substance
avatrombopag maleate
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0373/2019
PIP number
EMEA-001136-PIP01-11-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Powder for oral suspension
Condition(s) / indication(s)
  • Treatment of Idiopathic Thrombocytopenia Purpura (ITP)
  • Treatment of Thrombocytopenic Purpura Secondary to Liver Disease
Route(s) of administration
Oral use
Contact for public enquiries
Dova Pharmaceuticals Ireland Limited

Tel. +1 9197485975
E-mail: clinical@dova.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating